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n developing glomeruli, laminin 
 
 
 
5 replaces laminin 
 
 
 
1
in the glomerular basement membrane (GBM) at the cap-
illary loop stage, a transition required for glomerulogenesis.
To investigate domain-speciﬁc functions of laminin 
 
 
 
5
during glomerulogenesis, we produced transgenic mice that
express a chimeric laminin composed of laminin 
 
 
 
5 domains
VI through I fused to the human laminin 
 
 
 
1 globular (G)
domain, designated Mr51. Transgene-derived protein accu-
mulated in many basement membranes, including the devel-
oping GBM. When bred onto the 
 
Lama5 
 
 
 
/
 
 
 
 background,
Mr51 supported GBM formation, preventing the breakdown
that normally occurs in 
 
Lama5 
 
 
 
/
 
 
 
 glomeruli. In addition,
podocytes exhibited their typical arrangement in a single
cell layer epithelium adjacent to the GBM, but convolution
I
 
of glomerular capillaries did not occur. Instead, capillaries
were distended and exhibited a ballooned appearance, a
phenotype similar to that observed in the total absence of
mesangial cells. However, here the phenotype could be
attributed to the lack of mesangial cell adhesion to the
GBM, suggesting that the G domain of laminin 
 
 
 
5 is essential
for this adhesion. Analysis of an additional chimeric trans-
gene allowed us to narrow the region of the 
 
 
 
5 G domain
essential for mesangial cell adhesion to 
 
 
 
5LG3-5. Finally,
in vitro studies showed that integrin 
 
 
 
3
 
 
 
1
 
 and the Lutheran
glycoprotein mediate adhesion of mesangial cells to laminin
 
 
 
5. Our results elucidate a mechanism whereby mesangial
cells organize the glomerular capillaries by adhering to the
G domain of laminin 
 
 
 
5 in the GBM.
 
Introduction
 
Basement membranes are thin, sheetlike structures that abut
many cell types, including epithelia, endothelia, muscle, fat,
and peripheral nerve. They serve as extracellular barriers and
as substrates for cellular interactions. Basement membranes
are assembled through complex interactions among the major
components: laminins, collagen IV, perlecan, and nidogens
(Timpl, 1996). Of these components, it is well-known that
laminins regulate various cellular functions such as adhesion,
motility, growth, differentiation, and apoptosis through inter-
actions with specific cell surface receptors (Aumailley and
Smyth, 1998; Colognato and Yurchenco, 2000). All laminins
are composed of three subunits, designated 
 
 
 
, 
 
 
 
, and 
 
 
 
chains. Five 
 
 
 
, four 
 
 
 
, and three 
 
 
 
 chains have been identified.
To date, 15 different laminin heterotrimers have been found
to be synthesized and secreted by cells (Burgeson et al., 1994;
Miner et al., 1997; Koch et al., 1999; Libby et al., 2000),
although many more combinations are theoretically possible.
Of the three laminin chain types, only the 
 
 
 
 chain has a large
COOH-terminal globular (G)* domain consisting of a tandem
array of five small laminin-type globular (LG) modules
LG1 through LG5 (Timpl et al., 2000). These LG modules
contain binding sites for 
 
 
 
1 integrins and heparin, as well as
for 
 
 
 
-dystroglycan and the Lutheran blood group glyco-
protein  (Lu) in some isoforms (Talts and Timpl, 1999;
Kikkawa et al., 2002). Therefore, laminin 
 
 
 
 chains play pivotal
roles in laminin-mediated cellular functions.
Genetic inactivation of laminin 
 
 
 
 chains has also demon-
strated that they have specific functions. Mutation in laminin
 
 
 
2 results in congenital muscular dystrophy (Helbling-
Leclerc et al., 1995). Mutations in laminin-5 (
 
 
 
3
 
 
 
3
 
 
 
2
 
) subunits
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lead to junctional epidermolysis bullosa, a severe skin blister-
ing disease (Pulkkinen and Uitto, 1999). Targeted deletion
of laminin 
 
 
 
4 leads to impaired microvessel maturation and
aberrant localization of neuromuscular synaptic specializa-
tions (Patton et al., 2001; Thyboll et al., 2002). We have
shown that mice lacking laminin 
 
 
 
5 die during late embryo-
genesis with several developmental defects, including defects
in neural tube closure, digit separation, placentation, and
kidney and lung development (Miner et al., 1998; Miner
and Li, 2000; Nguyen et al., 2002).
In the kidney, basement membranes serve both as struc-
tural barriers for tubular epithelia and as a component of
the glomerular filter. The glomerular basement membrane
(GBM) contains an atypical assortment of basement mem-
brane protein isoforms, including laminin-11 (
 
 
 
5
 
 
 
2
 
 
 
1) and
collagen 
 
 
 
3–
 
 
 
5(IV) (Miner, 1998, 1999). There are transi-
tions in the basement membrane component isoforms that
are deposited in the developing GBM (Miner, 1998). Dur-
ing glomerulogenesis, transition of laminin isoforms is espe-
cially drastic (Miner et al., 1997; Sorokin et al., 1997a). The
nascent GBM initially contains laminin-1 (
 
 
 
1
 
 
 
1
 
 
 
1) and
laminin-8 (
 
 
 
4
 
 
 
1
 
 
 
1
 
), and laminin-10 (
 
 
 
5
 
 
 
1
 
 
 
1
 
) joins them at
the S-shape stage. By the capillary loop stage, laminin-1 is
eliminated from the GBM, and then laminin-9 (
 
 
 
4
 
 
 
2
 
 
 
1
 
)
and laminin-11 (
 
 
 
5
 
 
 
2
 
 
 
1
 
) begin to accumulate. At maturity,
only components of laminin-11 are detected in the GBM
(Miner, 1998, 1999). We have previously shown that mice
lacking laminin 
 
 
 
5 exhibit avascular glomeruli associated
with breakdown of the GBM during glomerulogenesis
(Miner and Li, 2000). This defect correlates with failure of
the developmental switch in laminin 
 
 
 
 chain deposition in
which 
 
 
 
5 replaces 
 
 
 
1 in the GBM at the capillary loop
stage. However, the specific role of laminin 
 
 
 
5 in the glo-
merulus is still undefined.
To investigate domain-specific functions of laminin 
 
 
 
5 in
developing glomeruli, we analyzed transgenic mice that ex-
press chimeric laminin 
 
 
 
 chains: Mr51 is composed of lami-
nin 
 
 
 
5 domains VI through I fused to the human laminin 
 
 
 
1
G domain; and Mr5G2 is composed of 
 
 
 
5 domains VI
through LG2 fused to human 
 
 
 
1LG3-5. These chimeras
were expressed on the genetic background of the laminin 
 
 
 
5
knockout (
 
Lama5 
 
 
 
/
 
 
 
). The developing kidney was ana-
lyzed by immunohistochemistry and transmission electron
microscopy. We found that the adhesion of mesangial cells to
the GBM via the G domain of laminin 
 
 
 
5 plays a key role in
capillary loop formation during glomerular development. In
vitro studies suggested that integrin 
 
 
 
3
 
 
 
1
 
 and Lu are the re-
ceptors that mediate binding of mesangial cells to laminin 
 
 
 
5.
 
Results
 
The developmental switch from laminin 
 
 
 
1 to 
 
 
 
5 
during glomerular development
 
As described in previous papers, transitions in laminin iso-
form deposition are quite dynamic during kidney develop-
ment and maturation of the GBM (Miner and Sanes, 1994;
Miner et al., 1997; Sorokin et al., 1997a). A crucial develop-
mental switch in laminin 
 
 
 
 chain deposition occurs in the
GBM when the laminin 
 
 
 
1 chain, which is predominantly
expressed in basement membranes of the S-shape body, is re-
placed by laminin 
 
 
 
5 in the capillary loop stage GBM (Fig. 1,
A–D). In 
 
Lama5 
 
 
 
/
 
 
 
 mutant glomeruli, where this switch
cannot occur, the kidney exhibits avascular glomeruli associ-
ated with GBM breakdown (Fig. 1, E and F). The GBM
breaks down because laminin 
 
 
 
1 is eliminated even in the ab-
sence of 
 
 
 
5 expression, and without a compensating full-
length laminin 
 
 
 
 chain, basement membrane structure can-
not be maintained. As a result of GBM breakdown, the cells
that comprise the glomerulus––podocytes, endothelial cells,
and mesangial cell––are unable to maintain their proper posi-
tions adjacent to the GBM, resulting in failed glomerulogene-
sis (Miner and Li, 2000). This demonstrates the extreme im-
portance of cell–matrix interactions during glomerulogenesis.
 
Expression of the chimeric laminin 
 
 
 
 chains, 
Mr51 and Mr5G2, in glomeruli
 
To begin to examine domain-specific functions of laminin
 
 
 
5, we produced transgenic mice expressing two different
full-length chimeric laminin 
 
 
 
 chains. These encoded lami-
nin 
 
 
 
5 domains VI through I and VI through LG2 fused to
the complete human laminin 
 
 
 
1 G domain and 
 
 
 
1LG3-5,
designated Mr51 and Mr5G2, respectively (Fig. 2, B and
C). We chose to use the human rather than mouse 
 
 
 
1 G do-
main because of the availability of mouse monoclonal anti-
bodies specific for the human domain (Virtanen et al.,
2000); thus, transgene-derived proteins could be specifically
localized in transgenic mouse tissues. A transgene encoding
the full-length mouse 
 
 
 
5 chain, designated Mr5 (Fig. 2 A),
served as a control. The widely active regulatory element
miw (Suemori et al., 1990) was used to drive transgene ex-
Figure 1. Laminin   chain switching and its importance during 
glomerulogenesis. From the S-shaped to the capillary loop stage of 
glomerular development, the laminin  1 chain (A and B) is replaced 
by the laminin  5 chain (C and D) in the GBM, though  1 continues 
to be expressed by proximal tubules seen in B. (E and F) Targeted 
mutation of Lama5 prevented this developmental transition, resulting 
in GBM breakdown and failed vascularization of glomeruli. Sections 
shown are toluidine blue–stained plastic sections of E18.5 control 
and Lama5  /  kidneys. S, S-shaped structure; G, glomerulus. 
Bars: (A and C) 100  m; (B and D–F) 50  m.T
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pression. As described in our previous papers, transgene-
derived laminin levels were significantly increased in heart
and skeletal muscle (Moulson et al., 2001; Kikkawa et al.,
2002). Crossing of the Mr5 transgene onto the Lama5  / 
background revealed that transgene-derived laminin  5 was
deposited widely in basement membranes. Expression was
sufficient to fully rescue all known Lama5  /  embryonic
defects in two independent lines, and the resulting Lama5
 / ; Mr5 mice are viable and fertile (unpublished observa-
tions). These results show that the miw regulatory element
directs expression of the transgene in a manner sufficient to
replace the missing endogenous  5 wherever it is necessary.
Expression of the two chimeric laminins was also wide-
spread, as determined by staining with the anti–human  1
LG1–2 and LG4–5 domain antibodies (Kikkawa et al.,
2002; Fig. 3; unpublished data). The Mr51 and Mr5G2
transgenes were separately mated onto the Lama5 mutant ge-
netic background, but the resulting Lama5  / ; Mr51 and
Lama5  / ; Mr5G2 mice were not viable. Lama5  / ;
Mr51 embryos exhibited the same defects we initially re-
ported for Lama5  /  embryos (Miner et al., 1998), but the
incidence of exencephaly was reduced from 60% to  10%.
On the other hand, although defects in digit septation were
still observed, the Mr5G2 transgene improved the growth of
Lama5  /  embryos, which are usually smaller than con-
trols (Miner et al., 1998). This indicates that the chimeric
proteins have limited functions, and that the G domain of  1
cannot fully compensate for the missing  5 G domain.
In fetal kidney, Mr51 and Mr5G2 were detected in the
GBM on both the control and Lama5  /  genetic back-
grounds (Fig. 3, F–H and K), suggesting that incorporation
of the chimeric laminin chains into the GBM might be ca-
pable of preventing the breakdown normally observed in
Lama5  /  glomeruli. There was no apparent effect of the
chimeric laminins on Lama5  /  control glomeruli (Fig. 3,
E, F, and I), and the mice were healthy. However, the glo-
meruli of Lama5  / ; Mr51 and Lama5  / ; Mr5G2
embryos exhibited greatly reduced or absent capillary loop-
ing (Fig. 3, G, H, and K).
Identification of cell types in glomerular structures
To further investigate the effects of Mr51 and Mr5G2 on
glomerulogenesis, we used cell type–specific antibodies to
identify the three cell types found in glomeruli. Frozen sec-
tions of E17.5 control, Lama5  / , Lama5  / ; Mr51,
and Lama5  / ; Mr5G2 kidneys were stained with anti-
bodies to WT1, platelet endothelial cell adhesion molecule
(PECAM), and desmin to label podocytes, endothelial cells,
and mesangial cells, respectively (Fig. 4, green), and doubly
labeled with an anti–basement membrane antibody (Fig. 4,
red). In the control, podocytes were observed in a single cell
layer epithelium adjacent to the glomerular capillaries (Fig.
4 A), and mesangial cells, which provide tension to maintain
the glomerular capillary loop structure, were found associ-
ated with endothelial cells in the interior of the glomerulus
(Fig. 4 I). In the Lama5  /  mutant, the podocytes were in
disarray, and the endothelial cells and mesangial cells were
extruded from glomerulus, as we showed previously (Miner
and Li, 2000; Fig. 4, B, F, and J). In Lama5  / ; Mr51
glomeruli, the transgene-derived chimeric laminin chain
partially rescued the defects observed in the mutant. The
podocytes were arranged in a single cell layer (Fig. 4 C), and
the endothelial cells and mesangial cells were localized in the
interior of the glomerulus, similar to the control (Fig. 4, G
Figure 2. Structure of wild-type and chimeric laminin chains. The 
domains present in full-length laminin  5 (A), in the chimeric laminin 
  chains (B and C), and in full–length human  1 (D) are shown. 
(B) Mr51 contains human laminin  1 G domain linked to domains 
VI through I of mouse laminin  5. (C) Mr5G2 contains laminin  5 
domains VI through  5 LG2 fused to the human laminin  1LG3-5 
domain. Anti–mouse laminin  5 (*) and anti–human laminin  1 
LG1–2 (**) antibody epitopes are indicated.
Figure 3. Expression of the chimeric 
  chains, Mr51 and Mr5G2, in transgenic mice. 
Micrographs show E17.5 glomeruli from Lama5 
 /  (A and B), Lama5  / ; Mr5 (C and D), 
Lama5  / ; Mr51 (E and F), Lama5  / ; Mr51 
(G and H), Lama5  / ; Mr5G2 (I and J), and 
Lama5  / ; Mr5G2 (K and L) embryos. Sections 
were doubly stained with an antiserum to 
domains IIIb/IVa of laminin  5 (A, C, E, G, I, 
and K) and a mouse monoclonal antibody 
specific for human laminin  1 LG1–2 (B, D, F, 
H, J, and L). Although the chimeric laminins 
were assembled into the GBM, Lama5  / ; 
Mr51 and Lama5  / ; Mr5G2 glomeruli 
exhibited distended capillaries (G, H, and K). 
Arrowheads indicate the GBM. Bar, 50  m.T
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and K). These results suggest that the COOH-terminal por-
tion of laminin  5 is dispensable for the assembly of the
GBM and arrangement of podocytes. However, the great re-
duction in capillary looping (Fig. 4, C and K) is indicative of
a mesangial cell defect because a similar phenotype has been
observed in the total absence of mesangial cells in mice lack-
ing either PDGF B or PDGF receptor   (Lindahl et al.,
1998). Lama5  / ; Mr5G2 glomeruli exhibited a very sim-
ilar aberrant glomerular phenotype (Fig. 4, D, H, and L).
Analysis of glomerular ultrastructure and podocyte 
gene expression
To further investigate the fine structure of the GBM and ad-
jacent cells, we used transmission electron microscopy to vi-
sualize E17.5 control, Lama5  /  and Lama5  / ; Mr51
glomeruli (Fig. 5). In the control, the GBM was clearly visi-
ble between podocytes and endothelial cells (Fig. 5, A and
G). Mesangial cells were attached to the GBM at the bases of
the capillary loops (Fig. 5 D); this allows them to maintain
the glomerular capillary loop structure. In the Lama5  / 
glomerulus, the absence of laminin  5, coupled with the
programmed disappearance of laminin  1, resulted in
breakdown of the GBM by the late capillary loop stage (Fig.
5, B and E). In the Lama5  / ; Mr51 glomerulus, the ul-
trastructure of the GBM was similar to that observed in con-
trol (Fig. 5, C and H), confirming that the transgene-
derived chimeric laminin   chain must have been assembled
into the GBM, as previously demonstrated by immunofluo-
rescence (Fig. 3). This suggests that the short and long arm
regions of laminin  5 are sufficient for directing incorpora-
tion of the chimera into the GBM. Although podocytes ex-
tended foot processes in both control and Lama5   / ;
Mr51 glomeruli (Fig. 5, A, C, G, and H), there appeared to
be fewer processes in the latter. This may suggest that the  5
G domain has some role in inducing process extension.
However, slit diaphragms, the delicate tight and adherens
junctions–related structures that are required for glomerular
filtration (Kerjaschki, 2001; Miner, 2002), were observed
between many of those foot processes that did form (Fig. 5
H), indicating that this crucial aspect of podocyte differenti-
ation was progressing appropriately. To investigate this in
more detail, we used antibodies to slit diaphragm– and foot
process–associated proteins. The results were essentially sim-
Figure 4. Identification and localization of cell types in developing 
glomeruli. E17.5 control, Lama5  / , Lama5  / ; Mr51, and 
Lama5  / ; Mr5G2 frozen kidney sections (as indicated) were 
stained with antibodies to WT1 to label podocytes (A–H, green), 
PECAM to label endothelial cells (E–H, red), and desmin to label 
mesangial cells (I–L, green). Basement membranes were stained 
with anti–laminin   1 monoclonal antibody (A–D, red) or anti–
laminin-1 polyclonal antibody (I–L, red). In Lama5  / ; Mr51 or 
Mr5G2 glomeruli, the podocytes were arranged properly in a single 
cell layer at the periphery (C and D), and the glomerular endothelial 
cells were properly localized (G and H). However, defective capillary 
loop formation was observed, despite the presence of mesangial 
cells (K and L). Bar, 50  m.
Figure 5. Ultrastructural analysis of glomeruli. Low and high 
magnification electron micrographs show E17.5 glomeruli from 
control, Lama5  / , and Lama5  / ; Mr51 kidneys, as indicated. 
The normally continuous basement membrane underlying the 
podocytes in control (A and G, arrowheads) was disrupted in the 
Lama5  /  mutant (B and E, arrows). The chimeric laminin Mr51 
rescued assembly of the basement membrane and formation of 
podocyte foot processes on the Lama5  /  genetic background 
(C and H, arrowheads). In the control (D and I), mesangial cells (mc) 
bound the GBM (I, white line) to maintain the capillary loop (cl) 
structure. In Lama5  / ; Mr51 glomeruli (F and J), the ballooning 
of the capillaries, which were commonly filled with red blood cells 
(F, rbc), was associated with detachment of mesangial cells from the 
GBM (F, arrowheads; J, white line). However, podocytes (p) and 
endothelial cells (e) maintained their normal positions on either side 
of the GBM. To better present the structure of glomeruli, red blood 
cells were removed digitally in I and J.T
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ilar for the three genetic backgrounds; all podocytes ex-
pressed nephrin, CD2AP, podocin, and synaptopodin (un-
published data). The straightforward interpretation is that
neither GBM composition nor its integrity is relevant for ex-
pression of these proteins. However, it is important to note
that initiation of expression of these proteins has been
shown to occur as early as the S-shape stage of glomerular
development, when the GBM is structurally sound even in
the Lama5  /  background. Thus, we cannot rule out the
possibility that podocyte interactions with the basement
membrane at early stages are required for their proper differ-
entiation and gene expression in vivo.
Low power electron microscopic observations of Lama5
 / ; Mr51 glomeruli revealed distension of the glomerular
capillaries and detachment of mesangial cells from the GBM
(compare Fig. 5, F and J with Fig. 4, C and K). We con-
clude that the binding of mesangial cells to the  5 G do-
main, which is absent in Lama5  / ; Mr51 glomeruli, is
essential for maintenance of this normal capillary loop struc-
ture, an example of which is shown in the electron micro-
graphs from control glomeruli (compare Fig. 5, D and I
with Fig. 4 I). No such structure was ever observed in
Lama5  /  glomeruli (Fig. 5 E; unpublished data), which
are extremely disorganized (Miner and Li, 2000).
Molecular composition of the Lama5  / ; Mr51 
glomerular basement membrane
The distended capillaries observed upon substitution of
Mr51 transgene–derived protein for endogenous  5 could
result from secondary defects in basement membrane com-
position. For example, Kostka et al. (2001) recently reported
that 10–40% of glomeruli in fibulin-1–deficient mice ex-
hibit a similar capillary malformation. Thus, the distended
capillaries in Lama5  / ; Mr51 glomeruli could be second-
ary to the failure of fibulin-1 to incorporate into the GBM.
To investigate whether deposition of fibulin-1 or other
GBM components was altered in Lama5  / ; Mr51 glo-
meruli, we stained E17.5 kidney sections from control and
Lama5  / ; Mr51 fetuses with a panel of antibodies to
GBM proteins (Fig. 6; unpublished data). Fibulin-1 was de-
tected in both the GBM and the mesangial matrix on the
Lama5   / ; Mr51 background, suggesting that the dis-
tended capillary loops were not secondary to the absence of
fibulin-1. We also examined the expression of fibulin-2,
agrin, nidogen-1/entactin-1, nephronectin, perlecan, and
the collagen  3(IV) and  4(IV) chains, and in no case was
there a significant difference between control and Lama5  / ;
Mr51 glomeruli (Fig. 6). Again, this suggested that the de-
fects observed in Lama5  / ; Mr51 glomeruli are not due
to the disappearance of other GBM or mesangial matrix
components. However, we did find greatly reduced levels of
the laminin  2 chain (Fig. 7, E and G), whereas laminin  1
was present in both control and Lama5  / ; Mr51 matur-
ing glomeruli (Fig. 7, A and C).
Laminin  2 normally trimerizes with the laminin  5 and
 1 chains to form laminin-11, which is first detected at the
capillary loop stage of glomerulogenesis (Miner and Sanes,
1994; Miner et al., 1997). The paucity of laminin  2 in
Lama5  / ; Mr51 GBM indicates either that  2 does not
efficiently associate with the Mr51 chimera to form a trimer,
or that the trimer forms but does not efficiently incorporate
into the GBM. On the other hand,  2 did efficiently incor-
porate into the GBM in the presence of Mr5G2 (Fig. 7 H).
Although little is known about how specificity of laminin
trimerization or incorporation into basement membranes is
determined, these results suggest that it may be encoded in
the   chain G domain. Indeed, laminin  1 and  2 are only
rarely found in the same basement membrane (unpublished
observations), perhaps because the  1 G domain directs
preferential assembly with  1. Nevertheless, the laminin-3
trimer ( 1 2 1) has been isolated from placenta (Champli-
aud et al., 2000), suggesting that whatever code exists could
be cell type–specific. In any event, although laminin  2
knockout mice exhibit a congenital nephrotic syndrome
Figure 6. Deposition of ECM proteins in control 
and Lama5    ; Mr51 glomeruli. Sections of E17.5 
control and Lama5  / ; Mr51 kidneys were stained 
with specific antibodies to fibulin-1 (A and B), fibulin-2 
(C and D), agrin (E and F), nidogen-1/entactin-1 
(G and H), nephronectin (I and J), perlecan (K and L), 
collagen  3(IV) (M and N), and collagen  4(IV) 
(O and P). The mutant GBM had a composition very 
similar to the control. Bar, 50  m.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
192 The Journal of Cell Biology | Volume 161, Number 1, 2003
(Noakes et al., 1995), there is no capillary loop distension
similar to that observed here. Thus, these capillary loop de-
fects cannot be ascribed to lack of either  2 or any other
GBM component for which we have antibodies. The
straightforward conclusion is that mesangial cells organize
the glomerular capillary loops by adhering to the G domain
of laminin  5 in the GBM, and that they are unable to ad-
here to the  1 G domain modules present in the Mr51 and
Mr5G2 chimeras. These results point to  5LG3–5 as neces-
sary for effective mesangial cell adhesion.
Adhesion of mesangial cells to laminins in vitro
To further investigate interactions between mesangial cells
and the laminin  5 G domain, we turned to in vitro adhe-
sion assays that used primary human and rat mesangial cells
and purified laminin preparations. We have not yet been
able to isolate laminin trimers containing the chimeric  
chains, and G domain preparations were not available, so we
chose to use commercially available laminins. First, we com-
pared the abilities of laminin-10/11 ( 5 1/2 1) and laminin-1
( 1 1 1) to promote adhesion of mesangial cells. Quan-
titative analysis of both human and rat mesangial cell ad-
hesion to surfaces coated with increasing concentrations of
these proteins showed that laminin-10/11 had higher cell
adhesion activity than laminin-1, especially at the lower pro-
tein concentrations (Fig. 8, A and B). In addition, the cells
spread less well on laminin-1 than they did on laminin-10/
11 (unpublished data). These data provide an explanation as
to why mesangial cells adhere poorly to GBM containing
the  1 G domain (Fig. 5, F and J) but adhere well to normal
GBM containing the  5 G domain (Fig. 5, D and I). We
believe that these in vitro data using laminin trimers justify
our conclusions concerning adhesiveness of G domains be-
cause in vivo mesangial cells adhere to wild-type  5 but not
to Mr51, which contains  5 domains VI through I. Thus,
adhesion to laminin-10/11 trimers is likely mediated prima-
rily by the  5 G domain.
Identification of receptors mediating mesangial cell 
adhesion to laminin-10/11
We next wished to investigate the mechanism of mesangial
cell adhesion to the  5 G domain. Cell adhesion to laminin-
10/11 is mediated predominantly by the integrin family of
adhesion receptors (Kikkawa et al., 1998, 2000). Therefore,
we examined the effects of function-blocking monoclonal
antibodies against various integrin subunits on human me-
sangial cell adhesion to laminin-10/11 (Fig. 8 C). Anti–inte-
grin  3 and  1 antibodies significantly inhibited the adhe-
sion of human mesangial cells to laminin-10/11. On the
other hand, monoclonal antibodies to integrin  1,  2, and
 6 had no effect on adhesion, even when combined with the
anti–integrin  3 antibody (Fig. 8 C). Together, these results
indicate that integrin  3 1 is one primary receptor that me-
sangial cells use to adhere to laminin-10/11.
Recently, it has been reported that Lu, a member of the Ig
superfamily, is a potential nonintegrin receptor for the lami-
nin  5 chain (Lee et al., 1998; Udai et al., 1998; Parsons et
Figure 7. Expression of laminin   chains in glomeruli. Sections of 
E17.5 control (A and E), Lama5  /  (B and F), Lama5  / ; Mr51 
(C and G) and Lama5  / ; Mr5G2 (D and H) kidneys were stained 
with specific antibodies to laminin  1 (A–D) and  2 (E–H). Arrowheads 
indicate GBM. Laminin  2 was almost undetectable in Lama5  / ; 
Mr51 GBM (G), but Mr5G2 increased  2 accumulation (H), though 
it was somewhat lower than that in the control (E). Bar, 50  m.
Figure 8. Analysis of mesangial cell adhesion to laminins in vitro. 
96-well plates were coated with increasing concentrations of 
laminin-1 (closed squares) or laminin-10/11 (open circles) and 
incubated with mesangial cells at 37 C for 1 h. Human (A) and 
rat (B) mesangial cells readily attached to laminin-10/11, but were 
significantly less adherent to laminin-1. (C) Identification of receptors 
mediating adhesion of mesangial cells to laminin-10/11. Human 
mesangial cells preincubated with function-blocking antibodies 
against the indicated integrin subunits were added to laminin-10/11–
coated wells. Values are expressed as percentages of the number 
of cells adhering in the absence of monoclonal antibodies. Each 
column represents the mean of triplicate assays. Error bars show the 
standard deviation. Anti–integrin  3 and  1 antibodies partially 
inhibited the adhesion of human mesangial cells to laminin-10/11, 
indicating that integrin  3 1 is a primary receptor. (D) The effect of 
sol-Lu on adhesion of human mesangial cells to laminin-10/11. 
Sol-Lu had little inhibitory effect on its own, but cooperated with 
anti–integrin  1 antibodies to inhibit adhesion by  90%. This 
indicates that Lu cooperates with integrin  3 1 to mediate mesangial 
cell adhesion to laminin  5 in the GBM.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 The laminin  5 G domain in glomerulogenesis | Kikkawa et al. 193
al., 2001). A splice variant of Lu present in humans that
should also bind laminin  5 is known as basal cell adhesion
molecule (El Nemer et al., 1998; Zen et al., 1999). In our
previous studies, we showed that Lu is expressed on the sur-
face of a subset of muscle and epithelial cells in diverse tissues
adjacent to basement membranes containing the laminin  5
chain (Moulson et al., 2001). We have also identified Lu to
be a specific receptor for laminin  5 via binding to the  5 G
domain by using a recombinant form of soluble Lu (sol-Lu)
that contains only the Lu extracellular domain; in addition,
the presence of  5LG3 was required for binding (Kikkawa et
al., 2002). Lu was coexpressed with integrin  3 on mouse
mesangial cells in vivo (unpublished data). To examine
whether Lu is also involved in adhesion of mesangial cells to
laminin  5, sol-Lu was used in adhesion/inhibition assays
(Fig. 8 D). In theory, sol-Lu should bind Lu binding sites on
laminin  5 and prevent the Lu present on mesangial cells
from interacting with  5. Although sol-Lu alone had no ef-
fect on mesangial cell adhesion to laminin-10/11, a signifi-
cant inhibitory effect was observed when it was combined
with the anti–integrin  1 antibody (Fig. 8 D). Thus, Lu may
be a secondary receptor for adhesion of mesangial cells to
laminin-10/11. In addition, the fact that sol-Lu did not en-
hance the anti–integrin  3 antibody inhibition suggests that
there may be another integrin   subunit that is involved.
Discussion
We and others have previously shown that the laminin  5
chain is widely expressed in mice (Miner et al., 1995, 1997;
Sorokin et al., 1997b). Based on knockout studies, laminin
 5 has roles in several important developmental processes,
including neural tube closure, digit septation, placentation,
and lung and kidney development (Miner et al., 1998;
Miner and Li, 2000; Nguyen et al., 2002). We found that
most of the developmental defects are associated with base-
ment membrane breakdown or discontinuity resulting from
the absence of  5. Here, we have begun to investigate the
role of laminin  5 using a combined transgenic/knockout
approach, which effectively substitutes either all or part of
the  5 G domain with analogous segments of  1. The re-
sult is expression of full-length chimeric laminin   chains
capable of trimerizing with   and   chains and incorporat-
ing into basement membranes. A similar strategy was previ-
ously used in vitro to map a synaptic basement membrane
localization domain on the laminin  2 chain (Martin et al.,
1995). This approach has allowed us to uncover a laminin
 5 G domain–specific function in glomerulogenesis that
might never have been found through traditional knock-
outs. It also demonstrates the feasibility of using widely ex-
pressed transgenes encoding altered basement membrane
proteins to replace existing knocked out genes, effectively
generating knockins without the use of further gene target-
ing in ES cells.
Expression of the Mr51, and presumably Mr5G2, chi-
meric   chains on the Lama5  /  background was able to
rescue the breakdown of the GBM (Fig. 5) that normally oc-
curs in Lama5  /  glomeruli when laminin  1 is elimi-
nated (Miner and Li, 2000). The mechanism of  1 elimina-
tion is unknown; but if it is not purely transcriptional, then
it must somehow be selective for  1 because  5 is not elimi-
nated. It is likely that primary sequence differences or do-
main structural differences account for the selective elimina-
tion of  1. The G domain of  1, present in Mr51, could
have carried a signal for elimination, but our results suggest
this not to be the case because Mr51 was not eliminated. We
are continuing to investigate this interesting issue using ad-
ditional   chain transgenes.
The major defect in the Lama5  / ; Mr51 and Lama5
 / ; Mr5G2 embryos was ballooning of the glomerular
capillaries. This same defect was observed in mice lacking
mesangial cells due to absence of PDGFB/PDGF receptor  
signaling (Lindahl et al., 1998). However, in our case, me-
sangial cells were clearly present (Fig. 4, K and L, and Fig. 5
J), so we concluded that they must not be adhering properly
to the GBM to maintain capillary looping. As the only
known differences between normal and Lama5  / ; Mr51/
Mr5G2 GBMs are the G domain substitutions, and laminin
  chain G domains have been shown to harbor recognition
sites for numerous cell adhesion receptors (Colognato and
Yurchenco, 2000), we hypothesized that mesangial cells nor-
mally adhere to the  5 G domain but were unable to adhere
tightly to either the complete  1 G domain or to  1 LG3–
5. Our in vitro studies confirmed that both human and rat
mesangial cells adhere better to  5-containing laminins than
to  1-containing laminin (Fig. 8, A and B).
With regard to mechanisms for mesangial adhesion to the
 5 G domain, mesangial cells express several  1 integrins,
including  1 1,  2 1,  3 1,  5 1,  6 1, and  8 1 (Gauer et
al., 1997; Sterk et al., 1998; unpublished observations). Fur-
thermore, immuno-EM studies have shown that  1-con-
taining integrins are concentrated at the mesangial cell
surface adjacent to the GBM and the mesangial matrix
(Kerjaschki et al., 1989). Antibody inhibition studies dem-
onstrated that integrin  3 1 plays a major role in mesangial
cell adhesion to laminin-10/11 (Fig. 8). In support of this,
the glomerular capillaries of Itga3  /  kidneys are dilated
(Kreidberg et al., 1996), suggesting a defect in mesangial ad-
hesion to the GBM but the fact that the capillaries are not
ballooned suggests that another receptor normally cooper-
ates with  3 1 and is able to partially compensate in Itga3
 /  mesangial cells. We found that Lu is expressed on
mouse mesangial cells and cooperates with  1 integrins to
mediate adhesion in vitro (unpublished data; Fig. 8 D). The
fact that Lu was found to be involved is consistent with the
fact that Mr5G2 does not support capillary loop formation
in vivo, because we have shown that sol-Lu does not bind
Mr5G2 (Kikkawa et al., 2002). Lu mutant mice being gen-
erated in our laboratory will allow us to more directly ad-
dress the function of Lu in glomerulogenesis.
An important issue to consider here is the relationship of
mesangial cells with laminins in the mesangium, a non–base-
ment membrane ECM, which mesangial cells secrete and in
which they are embedded. Several different laminins are
found in the mesangium, including substantial amounts of
laminins-1 ( 1 1 1), -2 ( 2 1 1), and -10 ( 5 1 1), but oth-
ers can be detected at lower levels (Miner, 1999). It has not
been possible to determine the relative levels of these lami-
nins, but one would suspect that, based on our findings, de-
creased levels of laminin-10 or increased levels of laminin-1,T
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as might occur in disease states, could correlate with reduced
adhesion of mesangial cells to the mesangial matrix. On the
other hand, the fact that mesangial cells are almost totally
surrounded by their matrix may make this issue irrelevant, as
weaker adhesion may be tolerated, both in disease and in nor-
mal states. This would be in contrast to the relationship of
mesangial cells to the GBM, with which they make contact
only at the bases of the capillary loops. A more robust adhe-
sion to the GBM may be necessary in this setting of limited
contact in order to counteract the force of blood pressure.
Therefore, interaction with the G domain of  5, normally
the only   chain in the GBM, would ensure a tight adhesion.
Two other laminin mutant mice with kidney defects have
been described. In mice lacking laminin  2, the  1 chain
compensates and allows an ultrastructurally normal basement
membrane to form. However, the glomerular filter fails as a
barrier to plasma proteins, and the mice die at 3 wk of age
with massive proteinuria (Noakes et al., 1995). No defects in
capillary looping were observed, consistent with the fact that
laminin  5, as part of laminin-10 ( 5 1 1), is present in
the GBM (unpublished observations); thus, mesangial cells
should still be capable of binding to the GBM and maintain-
ing capillary looping. On the other hand, mice lacking the
binding site for nidogen on laminin  1 exhibit glomerular
capillary aneurysms similar to the ballooned capillaries we
have reported here. The aneurysms were associated with
GBM discontinuities (Willem et al., 2002), and we suggest
that these GBM defects prevent mesangial cells from adher-
ing and maintaining the integrity of the capillary loops.
Integrin   3 1 is expressed basally on podocytes (Kor-
honen et al., 1990; Kreidberg et al., 1996), yet detachment
of podocytes from the GBM in Lama5  /  Mr51/Mr5G2
glomeruli, as occurred with mesangial cells, was not ob-
served. There are two possibilities to explain this. First,
integrin  3 1 on podocytes may serve primarily as a signal
transducing receptor rather than as an anchoring one. Dys-
troglycan is also expressed on podocytes but not on mesan-
gial cells (unpublished data), and together with Lu, this may
be sufficient for adhesion of podocytes to the GBM. Second,
podocytes and mesangial cells may be adhering only weakly
to the chimeric laminins through integrin  3 1. This may be
sufficient for long-term adhesion of podocytes to the GBM
but not for mesangial cells. Capillary looping was evident in
immature Lama5  / ; Mr51/Mr5G2 glomeruli, but me-
sangial cell adhesion to the GBM was apparently too weak
to counteract the force of blood pressure, leading to de-
adhesion and capillary ballooning. In support of this is our
finding that adhesion activity of laminin-10/11 ( 5 1/2 1)
was stronger than that of laminin-1 ( 1 1 1) for both hu-
man and rat mesangial cells (Fig. 8, A and B).
In conclusion, the laminin  5 chain plays a crucial role
in maintaining glomerular capillary loop structure. We
mapped the adhesive site in vivo to the LG3–5 modules of
the G domain. Adhesion of mesangial cells to the laminin
 5 G domain is mediated by integrin  3 1 and Lu. Mesan-
gial cells express contractile proteins and are similar to
smooth-muscle cells. Their frequency and extent of contrac-
tion in response to vasoactive substances are thought to de-
termine the glomerular filtration rate. It is interesting to
speculate that defective interactions between mesangial cells
and laminin  5 in the GBM may be a feature of diverse
glomerulopathies in the adult kidney.
Materials and methods
Proteins and antibodies
Mouse laminin-1 ( 1 1 1) and human laminin-10/11 ( 5 1/ 2 1) were pur-
chased from Invitrogen. Soluble recombinant Lu extracellular domain (sol-
Lu) was produced and characterized as described previously (Kikkawa et
al., 2002). Monoclonal antibody against human laminin  1 LG1–2
(161EB7) has been described previously (Virtanen et al., 2000). Rat mono-
clonal antibody 8B3 to laminin  1 (Abrahamson et al., 1989) was a gift
from Dr. D. Abrahamson (University of Kansas Medical Center, Kansas
City, KS). Polyclonal antibodies against laminin-1 (Sanes et al., 1990) and
agrin were gifts from Dr. J. Sanes (Washington University School of Medi-
cine, St. Louis, MO). Rat monoclonal antibodies MAB1914 to laminin  1,
MAB1946 to entactin/nidogen-1, and MAB1948 to perlecan were pur-
chased from CHEMICON International, Inc. Polyclonal antibodies against
the following mouse laminins and fibulins were gifts from Drs. R. Timpl
and T. Sasaki (Max-Planck Institute, Martinsried, Germany): domain VI of
laminin  1, domain IV of laminin  1, domain IV of laminin  2, fibulin-1C,
and fibulin-2 (Pan et al., 1993; Ettner et al., 1998; Sasaki et al., 2002). Rat
monoclonal antibodies against collagen  3(IV) (H31) and  4(IV) (H43)
chains have been described previously (Ninomiya et al., 1995). Rabbit an-
tibody against nephronectin (Brandenberger et al., 2001) was a gift from
Dr. L. Reichardt (University of California, San Francisco, San Francisco,
CA). Rabbit antibody against domain IIIb/IVa of mouse laminin  5 was
produced and characterized as described previously (Miner et al., 1997).
Rat monoclonal antibody MEC 13.3 to PECAM was purchased from BD
Biosciences. Rabbit antiserum sc-192 to Wilms’ tumor protein (WT1) was
purchased from Santa Cruz Biotechnology, Inc. Mouse monoclonal anti-
body D33 to desmin was purchased from DakoCytomation. Mouse mono-
clonal antibody to synaptopodin (Mundel et al., 1991) was a gift from Dr.
P. Mundel (Albert Einstein College of Medicine, Bronx, NY). Rabbit anti-
bodies to CD2AP, nephrin, and podocin have been described previously
and were gifts from A. Shaw (Washington University School of Medicine),
L. Holzman (University of Michigan Medical School, Ann Arbor, MI), and
C. Antignac (Necker Hospital, Paris, France; Dustin et al., 1998; Holzman
et al., 1999; Roselli et al., 2002). Monoclonal antibodies against human in-
tegrin  1 (FB12),  2 (P1E6),  3 (P1B5), and  6 (GoH3) were purchased
from CHEMICON International, Inc.
Preparation of the chimeric laminin constructs
Preparation of the chimeric laminin   chains, designated Mr51 and
Mr5G2, has been described in Kikkawa et al. (2002). Both chimeric lami-
nin cDNAs were cloned into a modified version of the widely active ex-
pression vector miw, which contains the RSV LTR inserted into the chicken
 -actin promoter (Suemori et al., 1990).
Generation of knockout and transgenic mice
Production of Lama5 mutant mice and of transgenic mice expressing a full-
length laminin  5 transgene or the chimeric laminin transgenes has been
described previously (Miner et al., 1998; Moulson et al., 2001; Kikkawa et
al., 2002). Five independent Mr51 lines, all of which gave similar results,
and one Mr5G2 line were produced.
Immunohistochemistry
For immunohistochemistry, mouse embryos from timed matings were fro-
zen whole by immersing in OCT compound and quick-freezing in 2-meth-
ylbutane cooled in a dry ice ethanol bath. Sections were cut at 7  m in a
cryostat and air-dried. For staining, sections were blocked in 10% normal
goat serum and incubated with primary antibody. All antibody incubations
were in PBS containing 1% BSA, and all washes were in PBS. Secondary
antibodies were conjugated to FITC (ICN Biomedicals) or Cy3 (CHEMI-
CON International, Inc.). After several washes, sections were mounted in
90% glycerol containing 0.1   PBS and 1 mg/ml p-phenylenediamine.
Sections were examined through a microscope (Eclipse E800; Nikon). Im-
ages were captured with a Spot 2 cooled color digital camera (Diagnostic
Instruments) using Spot Software Version 2.1. Images were imported into
Adobe Photoshop 5.0 and Adobe Illustrator 9.0 for processing and layout.
For semi-thin and thin sectioning, embryonic kidneys were fixed in 4%
paraformaldehyde, 4% glutaraldehyde in 0.1 M cacodylate buffer and pro-
cessed as described previously (Noakes et al., 1995). 2- m sections were
cut with a glass knife and stained with toluidine blue for light microscopy.T
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Thin sections were cut with a diamond knife and stained with lead citrate
plus uranyl acetate for transmission electron microscopy. Reagents were
obtained from Polysciences Inc.
Cell culture and adhesion assay
Normal human mesangial cells were purchased from Cambrex Life Sci-
ence Corporation. Cells were grown in MsGM medium supplied by Cam-
brex Life Science Corporation and used within seven passages. Primary rat
mesangial cells were provided by Q. Yu and A.R. Morrison (Washington
University School of Medicine). Cells were grown in DME supplemented
with 20% FBS, 10  g/ml insulin, 1 mM glutamate, and 1 mM sodium pyru-
vate (Invitrogen) and used within seven passages. Adhesion assays were
performed as described previously (Kikkawa et al., 2000). In brief, 20  g/
ml of commercial laminin-10/11 was coated onto a 96-well plate (Nunc)
at 37 C for 1 h. The wells were blocked with 1% BSA. Mesangial cells
were trypsinized and allowed to recover in serum-free medium for  30
min and 100  l of mesangial cells at 10
5 cells/ml in DME were added to
the wells. After a 1-h incubation, the attached cells were stained with
0.2% crystal violet in 20% methanol for 10 min, 100  l of 1% SDS was
added to dissolve the cells, and absorbance was measured at 570 nm by
VERSAmax (Molecular Devices). To identify the receptors for laminin-10/
11, 10  g/ml of monoclonal antibodies against different integrins and the
recombinant sol-Lu protein were preincubated individually with mesangial
cells in a volume of 50  l of serum-free DME (5   10
3 cells/well) at room
temperature for 15 min. The preincubated cells were transferred to plates
coated with laminin-10/11 and incubated further at 37 C for 20 min. After
incubation, the attached cells were stained with 0.2% crystal violet in 20%
methanol for 10 min and counted under the microscope.
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